fda glp-1 compounding warning september 2025 Have patients been harmed by unsafe drug compounding? – Partnership for Safe Medicines FDA is short-sighted on compounding

Messages 31 Reaction score 63 Points 398 Arrma RC's Typhon 6s #12 Very informative thread so far

Now, next-generation amylin agonists like cagrilintide deliver 10-12% body weight loss with weekly dosing, and when combined with GLP-1s in protocols like CagriSema, produce 15-25% weight loss - approaching bariatric surgery results

Adverse effects of 5-reductase inhibitors: What do we know, dont know, and need to know

We are thankful to Dr Jean Kim and the Human Stem Cell Core at Baylor College of Medicine for mediating the cell transfer, Dr Tobias Dick for Grx1-roGFP2 plasmid, and Drs Vsevolod Belousov, Luke Lavis, and Catherine Goodman for thoughtful discussions

The active compound then binds to and activates a receptor called Peroxisome Proliferator-Activator Receptor Alpha (PPAR)-alpha

Darker skin tones, since they contain more melanin, have a better natural barrier against UV rays